GlobeNewswire by notified

Catcha Investment Corp and Crown LNG Holdings AS Announce Effectiveness of Registration Statement for Proposed Business Combination

Share

Extraordinary General Meeting of Catcha Shareholders to Approve Proposed Business Combination to be Scheduled on March 6, 2024

SINGAPORE and OSLO, Norway, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Catcha Investment Corp (NYSE American: CHAA) (“Catcha”), a publicly traded special purpose acquisition company, and Crown LNG Holdings AS (“Crown”), a leading provider of LNG liquefaction and regasification terminal infrastructure solutions for harsh weather locations, today announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective the Registration Statement on Form F-4, as amended (the “Registration Statement”), in connection with the previously announced proposed business combination between the two companies (the “Business Combination”).

An extraordinary general meeting of Catcha shareholders (the “Special Meeting”) to approve the Business Combination is scheduled to be held on March 6, 2024 at 9:00 a.m. Eastern Time. The Special Meeting will be held in person at the offices of Goodwin Procter LLP, 620 8th Avenue, New York, New York 10018 and virtually via live audio webcast. Holders of Catcha’s Class A ordinary shares and Class B ordinary shares at the close of business on the record date of January 16, 2024 are entitled to notice of the Special Meeting and to vote at the Special Meeting. Catcha expects to file the definitive proxy statement/prospectus relating to the Business Combination with the SEC and begin mailing it to shareholders on or about February 15, 2024. The definitive proxy statement/prospectus contains a notice and proxy card relating to the Special Meeting and more details about the Business Combination and the resolutions to be voted upon at the Special Meeting can be found in the definitive proxy statement /prospectus.

Assuming satisfaction or waiver of the conditions to the closing of the business combination, including approval of the business combination by Catcha’s shareholders, the parties anticipate that the Business Combination will close and the combined company’s ordinary shares and warrants will commence trading on the New York Stock Exchange or the Nasdaq Capital Market under the new ticker symbols “CGBS” and “CGBSW,” respectively, shortly thereafter.

“We are pleased to have reached this important milestone on our journey to becoming a public company,” said Swapan Kataria, CEO of Crown. “The LNG market is supported by strong tailwinds, including rising energy security concerns and the increasing use of natural gas as a transition fuel with a tenth of the emissions of coal fired power plants. We believe this transaction will enable us to provide investors with a stable, long-term return on their investment while meeting the strong and growing global demand for harsh weather LNG infrastructure.”

“This is an exciting milestone for the Business Combination,” said Patrick Grove, Chairman and Chief Executive Officer of Catcha and Chief Executive Officer of Catcha Group. “We appreciate the support from our investors and remain confident that Crown’s differentiated technology is well-positioned to help enable LNG access for under-served markets which have been traditionally underserved by existing operators.”

Every vote is important and Catcha encourages all shareholders to make their voices heard by voting online or by mail as soon as possible, regardless of the number of shares held. Catcha shareholders who need assistance in completing the proxy card, need additional copies of the proxy statement/prospectus, or have questions regarding the Special Meeting may contact Catcha’s proxy solicitor, Morrow Sodali LLC, by calling (800) 662-5200 (toll free), or banks and brokers can call (203) 658-9400, or by emailing CHAA@investor.morrowsodali.com. 

About Crown LNG Holdings AS

Crown LNG Holdings AS is a leading provider of offshore LNG liquefaction and regasification terminal infrastructure solutions for harsh weather locations, which represent a significant addressable market for bottom-fixed, gravity based liquefaction and regasification plants, as well as associated green hydrogen, ammonia and power projects. Through this approach, Crown aims to provide lower carbon sources of energy securely to under-served markets across the globe. Visit www.crownlng.com/investors for more information.

About Catcha Investment Corp

Catcha Investment Corp (NYSE American: CHAA) is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Catcha is led by Chief Executive Officer Patrick Grove and Chief Financial Officer Wai Kit Wong, and is sponsored by Catcha Group, one of the earliest and most established new economy-focused investment groups in Southeast Asia and Australia.

Important Information and Where to Find It

In connection with the Business Combination, Crown filed the Registration Statement with the SEC, which includes a proxy statement/prospectus to be distributed to holders of ordinary shares of Catcha in connection with Catcha’s solicitation of proxies for the vote by Catcha’s shareholders with respect to the Business Combination and other matters as may be described in the Registration Statement, as well as a prospectus relating to the offer of securities to be issued to Crown equity holders in connection with the Business Combination. The Registration Statement has been declared effective by the SEC and Catcha is mailing a definitive proxy statement/prospectus and other relevant documents to its shareholders. The Registration Statement includes information regarding the persons who may, under the SEC rules, be deemed participants in the solicitation of proxies to Catcha’s shareholders in connection with the Business Combination. Catcha and Crown LNG Holdings Limited have filed and will file other documents regarding the Business Combination with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF CATCHA AND CROWN ARE URGED TO READ THE REGISTRATION STATEMENT, THE DEFINITIVE PROXY STATEMENT/PROSPECTUS CONTAINED THEREIN, AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION.

Investors and security holders will be able to obtain copies of the Registration Statement, the definitive proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by Catcha or Crown LNG Holdings Limited , without charge, once available, at the SEC’s web site at www.sec.gov. In addition, the documents filed by Catcha may be obtained free of charge from Catcha by directing a request to: Catcha Investment Corp, 3 Raffles Place #06-01, Bharat Building, Singapore 048617, Attention: Patrick Grove.

Participants in the Solicitation of Proxies

Catcha and its directors and executive officers may be deemed participants in the solicitation of proxies from Catcha’s shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in Catcha is contained in the registration statement on Form S-1, as amended, which was initially filed by Catcha with the SEC on January 25, 2021 and is available free of charge at the SEC’s web site at www.sec.gov, or by directing a request to Catcha Investment Corp, 3 Raffles Place #06-01, Bharat Building, Singapore 048617, Attention: Patrick Grove. Additional information regarding the interests of such participants may be obtained by reading the Registration Statement, the definitive proxy statement/prospectus and other relevant documents filed with the SEC when they become available.  

Crown’s directors and executive officers may also be deemed to be participants in the solicitation of proxies from Catcha’s shareholders in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination may be obtained by reading the Registration Statement, the definitive proxy statement/prospectus and other relevant documents filed with the SEC when they become available.

No Offer or Solicitation

This press release is for informational purposes only and shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination described herein. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws with respect to the Business Combination. These forward-looking statements include, without limitation, statements regarding the benefits of the Business Combination; expectations with respect to the future performance of the combined company following the Business Combination; the anticipated satisfaction or waiver of the closing conditions to the Business Combination and the anticipated timing of the completion of the Business Combination. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward looking statements. Although these forward-looking statements are based upon estimates and assumptions that Catcha and Crown believe are reasonable they are inherently uncertain and such estimates and assumptions may prove to be incorrect. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the risk that the Business Combination may not be completed in a timely manner or at all; (2) the potential failure to obtain an extension of the deadline by which to complete the Business Combination; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of Business Combination Agreement; (4) the outcome of any legal proceedings that may be instituted against Catcha, Crown, the combined company or others; (5) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of Catcha or to satisfy or waiver other conditions to closing; (6) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations; (7) the inability to maintain the listing of Catcha’s securities on NYSE American prior to the Business Combination; (8) the inability to meet stock exchange listing standards following the consummation of the Business Combination; (9) the risk that the Business Combination disrupts current plans and operations of Catcha or Crown as a result of the announcement and consummation of the Business Combination; (10) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (11) costs related to the Business Combination; (12) changes in applicable laws or regulations; (13) the possibility that Catcha, Crown or the combined company may be adversely affected by other economic, business, and/or competitive factors; (14) Crown’s estimates of expenses and profitability and underlying assumptions with respect to shareholder redemptions and purchase price and other adjustments; and (15) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Catcha’s registration statement on Form S-1, as amended, which was initially filed with the SEC on January 25, 2021, in its Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on April 24, 2023 and its subsequent Quarterly Reports on Form 10-Q, the Registration Statement, the proxy statement/prospectus contained therein, and any other documents filed (or to be filed) from time to time by Catcha with the SEC.   The foregoing list of factors is not exhaustive. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. 

Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date hereof. Unless required by law, none of Catcha or Crown undertakes any duty to update these forward-looking statements.

Investor Contacts
Caldwell Bailey
ICR, Inc.
CrownLNGIR@icrinc.com

Media Contacts
Zach Gorin
ICR, Inc.
CrownLNGPR@icrinc.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Constellation Brands to Present at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 202416.5.2024 22:30:20 CEST | Press release

VICTOR, N.Y., May 16, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Bill Newlands, President and Chief Executive Officer, and Garth Hankinson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024 in New York, NY. The presentation is scheduled to begin at 2:30 p.m. EDT and is expected to cover the company’s strategic business initiatives, financial metrics, and operating performance, as well as outlook for the future. A live, listen-only webcast of the presentation will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the presentation begins, financial information discussed in the presentation, and a reconciliation of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available

DBV Technologies Announces Results of its 2024 Combined General Meeting16.5.2024 22:30:00 CEST | Press release

Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting (the “General Meeting”). The General Meeting was chaired by Michel de Rosen, Chairman of the Company. The Company’s shareholders approved all resolutions submitted by the Board of Directors. These resolutions and their results are posted on the Investors/Annual General Meetings section of the Company’s website: https://dbv-technologies.com/events/2024-annual-general-meeting/. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with sign

Clean Motion AB delårsredogörelse för januari-mars 202416.5.2024 22:10:00 CEST | Pressemelding

Elfordonstillverkaren Clean Motion AB presenterar sin delårsrapport för januari-mars 2024. Bolaget redovisar en försäljning på 38 (45) TSEK och ett rörelseresultat exklusive avskrivningar (EBITDA) på -2 949 (-1 825) TSEK. Bolaget meddelar även att ett licensavtal är tecknat för tillverkning av Zbee i Indien samt att deras nya produktionslokal för EVIG i Jonsered nu är godkänd. Sofia Haby, VD kommenterar; ”Vi har jobbat intensivt under kvartalet med både typgodkännande-processen och flytt till nya lokaler. Kvartalet har präglats av de förseningar som vi drabbats av med vårt typgodkännande, vilket förhindrat försäljning i Europa. Jag kan nu med glädje meddela att det mest kritiska testet blev godkänt igår kväll! Under de senaste månaderna har vi jobbat med att färdigställa vår nya produktionslokal i Jonsered. Jag är övertygad om att vi genom att samla alla resurser under ett tak, kommer att åstadkomma stora effektivitetsförbättringar. Teamet har arbetat dedikerat med att säkerställa en s

Galapagos creates new subscription right plans16.5.2024 22:01:00 CEST | Press release

Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024 RMV,” intended for the employees of its French subsidiary, Galapagos SASU, and “Subscription Right Plan 2024 ROW”, primarily intended for the employees of its other non-Belgian subsidiaries, within the framework of the authorized capital. Under these subscription right plans, 1,614,000 subscription rights were created, subject to acceptances, and offered to the beneficiaries of the plans. The subscription rights have an exercise term of eight years as of the date of the offer and have an exercise price of €

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH16.5.2024 22:00:00 CEST | Press release

The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review by the DMC of safety data from more than 900 patients randomized in the main and exploratory cohorts, including more than 360 and 80 patients that have been treated for more than 48 and 72 weeks, respectively.The patient who experienced the adverse event of increased liver test results, which was reported as a SUSAR, has been without clinical symptoms throughout the period of observation and has fully recovered.The DMC review confirms the good safety profile of lanifibranor. Daix (France), Long Island City (New York, United States), May 16, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepa

HiddenA line styled icon from Orion Icon Library.Eye